FOCUS trial: results, potentialities and limits

Saba, Luca
Primo
;
Balestrieri, Antonella;Serra, Alessandra;Politi, Carola;Murgia, Alessandro;Mannelli, Lorenzo
2019-01-01

Abstract

In January 2019 Lancet has published the paper “Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial” (1). The main purpose of this prospective trial was to asses if fluoxetine [a selective serotonin reuptake inhibitor (SSRI) drug] could improve recovery after stroke.
2019
postischemic brain; reuptake inhibitor; stroke; fluoxetine
File in questo prodotto:
File Dimensione Formato  
atm-07-S3-S152(1).pdf

Solo gestori archivio

Dimensione 166.12 kB
Formato Adobe PDF
166.12 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie